The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis-Reference-Cited by-同舟云学术

The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis

Published:2013-03 Issue:1 Volume:53 Page:42-50
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Nelson Erik R.,Wardell Suzanne E.,McDonnell Donald P.

Funder

NIH

DOD

Novartis

Radius Health

Pfizer

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference106 articles.

1. The endocrine system and ageing;Chahal;J Pathol,2007

2. Endocrine aspects of menopause;Vagenakis;Clin Rheumatol,1989

3. Postmenopausal osteoporosis;Albright;Trans Assoc Am Physicians,1940

4. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment;Lindsay;Lancet,1976

5. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women;Heshmati;J Bone Miner Res,2002

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington’s Disease: Data from the TRACK and ENROLL HD Cohorts;Journal of Huntington's Disease;2024-09-05

2. Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data;Current Medical Research and Opinion;2024-08-18

3. Approach to Bone Health in the Patient With Breast Cancer;The Journal of Clinical Endocrinology & Metabolism;2024-06-12

4. Alamandine attenuates ovariectomy-induced osteoporosis by promoting osteogenic differentiation via AMPK/eNOS axis;BMC Musculoskeletal Disorders;2024-01-10